Our data now dramatically expands this current list of Zn transporters that are dysregulated in breast cancer, as we found that increased abundance of ZIP10 and loss of ZIP4, ZIP7, ZIP11, and ZnT9 were universal mechanisms associated with Zn hyper-accumulation in malignant breast cells. This evidence concerns the gene SLC39A11 and breast cancer.